We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Diagnostic performance of unenhanced computed tomography and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.
- Authors
Delivanis, Danae A.; Bancos, Irina; Atwell, Thomas D.; Schmit, Grant D.; Eiken, Patrick W.; Natt, Neena; Erickson, Dana; Maraka, Spyridoula; Young, William F.; Nathan, Mark A.
- Abstract
Objective Evidence on the diagnostic performance of adrenal imaging is limited. We aimed to assess the diagnostic performance of unenhanced computed tomography ( CT) and 18F-fluorodeoxyglucose (18FDG) positron emission tomography ( PET)/ CT imaging in a high-risk population for adrenal malignancy using an optimal reference standard. Design Retrospective cohort study. Methods Imaging studies of patients with adrenal nodules who underwent adrenal biopsy and/or adrenalectomy between 1994 and 2014 were reviewed and compared to the reference standard of histology. Eighty % of patients presented with known or suspected extra-adrenal malignancy. Results Unenhanced abdominal CT was performed in 353 patients with adrenal lesions; median size was 3 (0.7-15) cm and median radiodensity was 33 (−21-78) Hounsfield units ( HU). Radiodensity of >10 HU diagnosed malignancy with a sensitivity of 100%, specificity of 33%, positive predictive value ( PPV) of 72% and negative predictive value ( NPV) of 100%. 18 FDG- PET/ CT was performed in 89 patients; median tumour size was 2.1 (0.7-9.2) cm. Maximum standardized uptake ( SUV max) was higher in malignant lesions when compared to benign lesions (median=10 [2.3-29.4] vs 3.7 [1.4-24.5], respectively, P<.0001). Similarly, median SUV max lesion to SUV max liver ratio ( ALR) in malignant lesions was higher than in benign lesions (median=3 [0.74-13.4] vs 1.2 [0.5-6.6], respectively, P<.0001). 18 FDG- PET/ CT ALR >1.8 diagnosed malignancy with a sensitivity of 87%, specificity of 84%, PPV of 85% and NPV of 86%. Conclusion Noncontract CT radiodensity of ≤10 HU excludes malignancy even in a high-risk population. For indeterminate adrenal lesions, given a superior specificity, 18 FDG- PET/ CT could be considered as a second stage imaging study.
- Subjects
COMPUTED tomography; FLUORODEOXYGLUCOSE F18; DIAGNOSTIC imaging; ADRENALECTOMY; CANCER patients
- Publication
Clinical Endocrinology, 2018, Vol 88, Issue 1, p30
- ISSN
0300-0664
- Publication type
Article
- DOI
10.1111/cen.13448